Renal markers in normal and hypertensive disorders of pregnancy in Indian women:a pilot study

Padma Y, Aparna V B, Kalpana B, Ritika V, Sudhakar P R


Background:Altered renal function is an essential component of the pathophysiological process in pre-eclampsia. Kidneys play an important role in the turnover of low molecular weight substances such as creatinine, uric acid and cystatin C. The present study was undertaken if these serum markers were characteristically altered in Indian pregnant women.

Methods: Serum levels were therefore determined in samples from 69 healthy women at term as well as in 27 samples of patients with Pregnancy induced hypertension (PIH) and in 20 patients with pre-eclampsia (PE).

Results: The levels of all three components were significantly higher in pre-eclamptic patients when compared to healthy controls with the mean ± SD being 1.47 ± 0.9 vs. 1.06± 0.2 for cystatin C, 0.95 ±0.2 vs. 0.67 ±0.1 for creatinine and 6.13± 1.8 vs. 4.28 ±1.1 for uric acid respectively. In PIH cystatin C was significantly higher, 1.25 ± 0.9 unlike creatinine, 0.67 ±0.14 and uric acid, 4.30 ±1.0. Receiver operating characteristic (ROC) plots demonstrated that the diagnostic accuracy of serum creatinine was superior to serum uric acid and serum cystatin C and serum uric acid was better than serum cystatin C.

Conclusion:The maternal serum cystatin C, creatinine and uric acid were all significantly elevated at the end of pregnancy in pre-eclampsia compared to those of healthy pregnant women. If this rise in the above markers during early pregnancy could predict the onset of PIH/PE, needs to be investigated.



Pregnancy, Pregnancy induced hypertension, Pre-eclampsia, Cystatin C, Creatinine, Uric acid

Full Text:



Roberts JM, Gammill HS. Preeclampsia: Recent insights. Hypertension. Dec 2005; 46960:1243-1249.

Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy. 2003;22(20):203-212.

Kingdom J, C P, Jauniaux ERM Shaughn O'Brien P.M. The Placenta: Basic Science and Clinical Practice(RCOG-Press, London) 2000; Vol.1.

Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 1986; 93(10):1049-1059.

Pijnenborg R, Anthony J, Davey DA, et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98(7):648-655.

Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, VanAsshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1994; 101(8):669-674.

Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynaecol . 2002; 187(5):1416-1423.

Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP. Serum cystatin Cmeasured by automated immunoassay: a moresensitive marker of changes in GFR than serumcreatinine. Kidney Int 1995; 47: 312–8.

Jung K, Jung M. Cystatin C: a promising markerof glomerular filtration rate to replace creatinine. Nephron 1995; 70: 370–1.

H. Strevens, D. Wide-swensson& A. Grubb. Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate. Scand J Clin Lab Invest 2001; 61: 575–580

H. Strevens, D. Wide-swensson & A. Grubb, A. Hansen, T. Horn, I. Ingemarsson, S. Larsen, J R. Nyengaard, O. Torffvit, J. Willner, S. Olsen. Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies. BJOG: an international journal of Obstetrics and Gynaecology september 2003, Vol. 110, pp. 825-830.

N. Franceschini, C. Qiu,D A. Barrow, M A. Williams. Cystatin C and Preeclampsia: A Case Control Study. Renal Failure, 30:89–95, 2008.

B. Thilaganathan, E. Ralph, Aris T. Papageorghiou, K. Melchiorre, J. Sheldon. Raised maternal cystatin C: An early pregnancy marker for pre-eclampsia. Reproductive sciences, Vol. 16 No. 8 August 2009.

NovakovMikic A, Cabarkapa V, Nikolic A, Maric D, Brkic S, Mitic G, Ristic M, Stosic Z. Cystatin C in pre-eclampsia. J Matern Fetal Neonatal Med.2012 Jul;25(7):961-5.

Brown MA, Lindheimer MD, de Sweit M, VanAssche A, Mountquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the international society for the study of hypertension in pregnancy (ISSHP). Hypertens pregnancy. 2001; 20(1):IX-XIV

National committee for clinical laboratory standards. Procedures forthe collection of diagnostic blood specimens by venipuncture:Approved standard H3 - A4. 4th ed. Wayne PA: National committee for clinical laboratory standards, 1998.

National committee for clinical laboratory standards. Procedures for thehandling and transport of domestic diagnostic blood specimens and etiologic agents: Approved standard H5 – A3.3rd ed. Wayne PA: National committee for clinical laboratory standards, 1994.

Hazel Finney, David J. Newman, Walter Gruber, Peter Merle, and Christopher P. Price. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clinical Chemistry. 1997;43(6):1016–1022.

Larsen K. Creatinine assay by a reaction-kinetic approach. Clin Chem Acta. 1972; 41:209-217.

Knapp ML, Mayne, PD. Development of an automated kinetic jaffe method designed to minimize bilirubin interference in plasma creatinine assays. Clin Chem Acta. 1987; 168:239-246.

Bulgar HA, Johns HE. The determination of plasma uric acid, J Biol Chem 1941;140:427.

Kalckan HM. Differential spectrophotometry of purine compounds by means of specific enzymes, J Biol Chem 1947;167:429

Yoder, J.Adams, E.C.,and Free. H.M.: Simultaneous screening for urinary Occult blood , Protein, Glucose and pH.Amer.J. Med Tech.31:285;(1965).

Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561–77.

Lafayette RA, Druzin M, Sibley R, Derby G, Malik T, Huie P, Polhemus C, et al.Nature of glomerular dysfunction in pre-eclampsia. Kidney Int 1998; 54: 1240-1249.

Garovic VD, Wagner SJ, Turner ST, Rosenthal DW, Watson WJ, Brost BC, Rose CH, et al. Urinary podocyte excretion as a marker for pre-eclampsia. AM J ObstetGynecol 2007; 196: 320.e1-320.e7.

Babay Z, Al-Wakeel J, Addar M, Mittwalli A, Tarif N, Hammad D, Ali N, Al-Askar A, Choudhary AR. Serum cystatin C in pregnant women: reference values, reliable and superior diagnostic accuracy. Clin Exp Obstet Gynecol. 2005; 32 (3):175-9.

Fang Guiying, Zhou Changhao, Zhang HongZhen et al. The significance of cystatin C measurement in patients with preeclampsia-eclampsia.Progress In Obstetrics and Gynecology, 2005-03.

Norlund L, Fex G, Lanke J, von Schenck H, Nilsson JE, Leksell H, Grubb A. Reference intervals for the glomerular filtration rate and cellular proliferation markers: serum cystatin C and serum b2-micro-globulin-cystatin C-ratio. Scand J Clin Lab Invest 1997; 57: 463-70.

Cataldi L, Mussap M, Bertelli L, et al. Cystatin C in healthy women at term pregnancy and in their infant newborns: relationship between maternal and neonatal serum levels and reference values. Am J Perinatol 1995; 16: 287-95.

H. Strevens, D. Wide-swensson, O. Torffvit, A. Grubb. Serum cystatin C for assessment of glomerular flitration rate in pregnant and non pregnant women.Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest 2001;62(2): 141-147.

Dunlop W. Serial changes in renal haemodynamics during normal human pregnancy. Br J Obstet Gynaecol 1981; 88: 1-9.

Chapman AB, Abraham WT, Zamudio S, et al. Temporal relationships between hormonal and haemodynamic changes in early human pregnancy. Kidney Int 1998; 54: 2056-2063.

Akbari A.(2004) Glomerular endotheliosisin normal pregnancy and pre-eclampsia. Br J ObstedGynecol 111, 192

Kristensen K, Wide-swensson D, Schmidt C, Blirup-jensen S, Lindstrom V, Strevens H & Grubb A. Cystatin C, ß2 microglobulin and ß-trace protein in pre-eclampsia. Acta Obstetricia et Gynecologica. 2007; 86: 921- 926.

Sagen N, Haram K, Nilsen ST. Serum urate as a predictor of fetal outcome in severe pre-eclampsia. Acta Obstet Gynecol Scand 1984; 63: 71–5.

Schuster E, Weppelman B. Plasma urate measurements and fetal outcome in preeclampsia. Gynecol 39: 561–77. Obstet Invest 1981; 12: 162–7.

Fabrício da Silva Costa, Padma Murthi, Rosemary Keogh, Nicole Woodrow. Early screening for preeclampsia. Rev. Bras. Ginecol. Obstet. vol.33 no.11 Rio de Janeiro Nov. 2011.

Karl Kristensen, I. Larsson and S.R. Hansson. Increased cystatin C expression in thepre-eclamptic placenta. Molecular Human Reproduction 2007;13(3):189-195.